Veterinary Medicines

GALLIVAC IBD

Authorised
  • Infectious bursal disease virus, strain S706, Live
Download as PDF

Product identification

Medicine name:
GALLIVAC IBD
Active substance:
  • Infectious bursal disease virus, strain S706, Live
Target species:
  • Chicken
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Infectious bursal disease virus, strain S706, Live
    199526.00
    50% cell culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension/use in drinking water
Withdrawal period by route of administration:
  • Oral use
    • Chicken
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD09
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • Type I glass vials with butyl elastomer closure and aluminium cap, containing 1000 doses.Cartons containing 1 vial of 1000 doses.
  • Type I glass vials with butyl elastomer closure and aluminium cap, containing 2000 doses.Cartons containing 1 vial of 2000 doses.
  • Type I glass vials with butyl elastomer closure and aluminium cap, containing 2500 doses.Cartons containing 1 vial of 2,500 doses.
  • Type I glass vials with butyl elastomer closure and aluminium cap, containing 5000 doses.Cartons containing 1 vial of 5,000 doses.
  • Type I glass vials with butyl elastomer closure and aluminium cap, containing 1000 doses.Cartons containing 10 vials of 1000 doses.
  • Type I glass vials with butyl elastomer closure and aluminium cap, containing 2000 doses.Cartons containing 10 vials of 2000 doses.
  • Type I glass vials with butyl elastomer closure and aluminium cap, containing 2500 doses.Cartons containing 10 vials of 2,500 doses.
  • Type I glass vials with butyl elastomer closure and aluminium cap, containing 5000 doses.Cartons containing 10 vials of 5,000 doses.
  • Type I glass vials with butyl elastomer closure and aluminium cap, containing 1000 doses.Cartons containing 50 vials of 1000 doses.
  • Type I glass vials with butyl elastomer closure and aluminium cap, containing 2000 doses.Cartons containing 50 vials of 2000 doses.
  • Type I glass vials with butyl elastomer closure and aluminium cap, containing 2500 doses.Cartons containing 50 vials of 2,500 doses.
  • Type I glass vials with butyl elastomer closure and aluminium cap, containing 5000 doses.Cartons containing 50 vials of 5,000 doses.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10454/057/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download